Thyroid Eye Disease (TED) can also be referred to as Graves’ orbitopathy, Graves’ ophthalmopathy, Graves’ eye disease, thyroid-associated orbitopathy, or thyroid-associated ophthalmopathy.
In TED, the immune cells that attack the thyroid gland (to cause Graves’ disease) also attack adipose and fibroblast tissues around the eyes. TED, or Graves’ eye disease, is an autoimmune condition that is mainly driven by stimulation of the thyroid-stimulating hormone (TSH) receptor (TSHR). This receptor is mainly located in the thyroid gland but is also found in other tissues in the body such as the tissues around the eyes. The levels of these antibodies can determine the severity and prognosis of TED.
THE DEVELOPMENT OF THIS RESOURCE WAS MADE FROM THE GENEROUS SUPPORT OF OUR SPONSOR IMMUNOVANT, INC.
The Hormone Health Network is the public education affiliate of the Endocrine Society dedicated to helping both patients and doctors find information on the prevention, treatment and cure of hormone-related conditions.
All Network materials, including the content on this site, are reviewed by experts in the field of endocrinology to ensure the most balanced, accurate, and relevant information available. The information on this site and Network publications do not replace the advice of a trained healthcare provider.
Paid advertisements appear on the Hormone Health Network. Advertising participation does not influence editorial decisions or content.